PTEN, a putative tumour suppressor gene, has been mapped to 10q23.3. Mutations or allelic loss at PTEN have been reported in malignant turnours such as glioblastoma, melanoma, breast, prostate, a n d colorectal carcinomas; germ-line PTEN mutations have also been reported in some juvenile polyposis families.
To investigate PTEN in sporadic colorectal adenomas, we examined allele loss (LOH) a t D10S201. D10S215, D10S541 in microdissected tissues from 74 adenomas.
Fifty-seven cases were informative, with seven adenomas (12.3%) showing L O H a t one or more loci. The frequencies of L O H in adenomas with mild, moderate a n d severe dysplasia were 6.3% (1/16), 12.0% (3/25 ) a n d 18.8% (3/16), respectively, showing that loss of PTEN m a y be involved in a subset of adenomas. These figures are lower than the frequency of 35% reported in sporadic colorectal carcinomas, a n d generally lower than the accepted 20% threshold for a significant frequency of LOH. Thus, loss of PTEN would appear to be associated with carcinoma rather than adenoma. This is consistent with observations in other tumour types,
where FTEN mutation appears related to generally more advanced malignancies. Further work is needed to define the possible =mutations in these positive L O H cases. Apoptosis is regulated by a large number of oncoproteins. Bcl-2 protects against the development of apoptosis in a variety of normal and neoplastic tissues. The more recently described Bag-1 protein also suppresses apoptosis by a mechanism which is at least partly mediated via interaction with Bcl-2. In a previous study we demonstrated the differential expression of Bcl-2 in colonic crypt epithelium in a cytoplasmic distribution and the over-expression of Bcl-2 in colonic carcinomas and adenomas. In this study we studied a number of normal tissues and a series of colorectal adenomas and carcinomas for the expression of Bag-1 by immunohistochemistry using a polyclonal antibody. In normal skin immunoreactivity was present within most keratinocytes in a predominantly nuclear distribution with sparing of the granular layer. In the small intestine only occasional epithelial cells within the crypt were positive in a predominantly nuclear pattern. In the stomach positive staining was observed in a few mucus-secreting epithelial cells in the antrum again in a predominantly nuclear distribution but surface foveolar cells were negative. In the large intestine there was immunoreactivity of epithelial cells within the crypt and at the surface in both cytoplasmic and nuclear distributions. In most colonic adenomas and carcinomas there was strong nuclear staining; cytoplasmic immunoreactivity was also present in a stronger staining pattern than in adjacent non-neoplastic mucosa. These findings suggest a role for Bag-1 in colorectal neoplasia and are consistent with interaction with Bcl-2. The present study aims to determine the effect of HMBA on the mitochondria1 and nuclear components of LOVO (CCL-229) using electron microscopical and stereological techniques. 2mM and JmM of HMBA were included in the culture medium for a period of 7 days and then for a further 3 days HMBAcontaining medium was omitted. Control flasks were never exposed to HMBA. The nuclear-cytoplasmic ratio, volume density of mitochondria ( V~C ) , nucleolus (VVNCJ) . heterochromatin (Vmi~) and euchromatin (V,) were estimated using point counting. The nuclear volume (VN) was estimated from point-sampled intercepts. From these data cytoplasmic volume (VCYI), cell volume (V,,,,), average volume of mitochondrion per cell (VM,~) and average volume of nucleolus (VVN~J), hetsochromatin (VIiN) and euchromatin ( V~N ) per nucleus were calculated. The general trend for the average volumes of the mitochonrion and nucleolus decreased and the heterochromatin increased in HMBA-treated groups when compared with the control. There was a denease in VW.C on day 3 to day 10 of the culture period with the control groups having the highest value when compared with the HMBA-treated ones. However, statistical significant differences were only detected on day 3 in the 4mM HMBA-treated group and on day 10 in both HMBA-treated groups. Similar reduction in the values of V~C were observed except that the HMBA-treated groups had values higher than the control on day 10 but no significant difference was detected in all time points amongst the tested groups. Significant decrease in VVNC,N was observed on day I to day 5 in HMBA-treated groups. Similar trend was observed in VN~,N and significant difference was only observed on day I between HMBA-treated and control groups. No statistical significant difference was detected in VNC.N, V~K N . VKN. VW.N and VBN between HMBA-treated and control groups from day 1 to day 10. We concldde that HMBA has no significant effect on the nuclear and cellular metabolic activity in the human colonic carcinoma cell line (LOVO). Supported by the Committee on Research and Conference Grants, The University of Hong Kong.
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